Results 181 to 190 of about 2,387 (195)

Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024

Journal of Infection
Ushma Wadia, Catherine Pienaar, Lana Bell   +2 more
exaly  

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024

Influenza and Other Respiratory Viruses
Sophie Vaux, Cecile Durand, Milési Christophe   +2 more
exaly  

Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023–March 2024: a test-negative design analysis

The Lancet Regional Health Americas
Stephanie A. Irving, Elizabeth Rowley, Brian E. Dixon   +2 more
exaly  

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants

Vaccine
April Killikelly, Man Wah Yeung
exaly  

Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case–control study

Lancet Regional Health - Europe, The
Andreas Werner, Corinne Levy, Stéphane Bechet   +2 more
exaly  

Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study

Lancet Regional Health - Europe, The
Romain Anne-Sophie, Robert Cohen, Valérie Biran   +2 more
exaly  

Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY)

Vaccine
Tonya Villafana, Vaishali S Mankad, Kevin M Tuffy   +2 more
exaly  

Will Nirsevimab Reduce the Burden on Public Health Care?—Reply

JAMA Pediatrics
Heidi L, Moline, Meredith L, McMorrow, Fatimah S, Dawood   +2 more
openaire   +2 more sources

Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists

Hospital Pediatrics
Elena, Aragona, Neha S, Joshi, Krista L, Birnie, Poj, Lysouvakon, Rakhi Gupta, Basuray   +4 more
openaire   +2 more sources

Nirsevimab Immunisation Significantly Reduces Respiratory Syncytial Virus-Associated Bronchiolitis Hospitalisations and Alters Seasonal Patterns

Acta Paediatrica, International Journal of Paediatrics
Juan Manuel Rius-Peris, Raúl Alcaraz
exaly